Cathie Wood Crispr Therapeutics Ag Transaction History
Ark Investment Management LLC
- $10.5 Billion
- Q3 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ark Investment Management LLC holds 7,498,625 shares of CRSP stock, worth $305 Million. This represents 3.35% of its overall portfolio holdings.
Number of Shares
7,498,625
Previous 7,778,536
3.6%
Holding current value
$305 Million
Previous $420 Million
16.13%
% of portfolio
3.35%
Previous 3.82%
Shares
30 transactions
Others Institutions Holding CRSP
# of Institutions
490Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$323 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$122 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$121 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$121 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$113 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.18B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....